Comments
Transcript
Francesca Renda - European Medicines Agency
Curriculum vitae PERSONAL INFORMATION Francesca Renda WORK EXPERIENCE January 2006–March 2006 researcher National Center of Research (Italy) molecular biology March 2006–Present Pharmacist Italian Regulatory Agency (Italy) Pharmacovigilance EDUCATION AND TRAINING September 1999–July 2005 University Degree - Pharmaceutical Chemistry and Technology University (Italy) September 2010–December 2010 Master degree University (Italy) HTA report September 2005–July 2007 University Degree - Pharmacy University (Italy) ADDITIONAL INFORMATION Expertise Pharmacovigilance assessor Contact point for many european procedures Member of National and European groups of Pharmacovigilance experts Author of scientific pubblications on pharmacovigilance issues and abstracts Task Force of National Competent Authority Tutor for students Publications 1. Annabella Vitalone, Francesca Menniti-Ippolito, Paola Angela Moro, Roberto Raschetti, Francesca Renda, Loriana Tartaglia, Gabriela Mazzanti Surveillance of suspected adverse reactions to herbal health products used as laxatives. Eur J Clin Pharmacol DOI 10.1007/s00228-011-1128-y 2. Carla Carnovale • Tatiana Brusadelli • Maria Luisa Casini • Francesca Renda • Sara Ruggieri • Giuseppe Pimpinella • Sonia Radice • Emilio Clementi Drug-induced anaemia: a decade review of reporting to the Italian Pharmacovigilance data-base Int J Clin Pharm DOI 10.1007/s11096-014-0054-3 3. Renda F., Finco G, Mura P, Ferrazin F., Pani L., Landoni G. Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. European Review for Medical and Pharmacological Sciences 4. F. Renda, E. Marotta, E. Xoxi, E. Donnarumma, L. De Nigro, A. Scurti, L. Catalano, F. Ferrazin, C. Tomino Appropriateness and Safety of Thalidomide. The implementation of Pregnancy Prevention Plans in Italy via the Cancer Drugs Register (RFOM) and the National Pharmacovigilance Network (RNF) of the Italian Medicines Agency (AIFA). I.S.O.P. 2010 5. L. Sottosanti, F.Renda, C. Santuccio, N.G. Mangano, P.Porcelli, M. Venegoni ‘Telitromycin and 10/12/15 © European Union, 2002-2015 | http://europass.cedefop.europa.eu Page 1 / 2 Curriculum vitae Francesca Renda ocular reactions’ Drug Safety. 29(10):911-1010, 2006 6th ISoP Annual Meeting Liegi, Belgio 11-13 Ottobre 2006. 6. Renda F., Marchione P., Di Girolamo M., Catalano L., R.Bertini Malgarini, G. Pimpinella Drug reaction with eosinophilia and systemic symptoms (DRESS) and antiepileptic drugs (AEDs): a case-non case approach from European Pharmacovigilance Database. Atti del convegno I.S.O.P. 2015 Prague, 27-30 October 2015 7. Francesca Renda1, Giovanni Landoni2,3, Francesco Trotta1, Desiderio Piras4, Gabriele Finco4, Patrizia Felicetti1, Giuseppe Pimpinella1, Luca Pani1 KOUNIS SYNDROME: AN ANALYSIS OF SPONTANEOUS REPORTS FROM INTERNATIONAL PHARMACOVIGILANCE DATABASE International Journal of Cardiology – International Journal of Cardiology 203 (2016) 217–220 8. Francesca Renda, Giovanni Landoni, Renato Bertini Malgarini, Alessandro Assisi, Maria Luisa Azzolini, Marta Mucchetti, Giuseppe Pimpinella, Luca Pani Drug reaction with eosinophilia and systemic symptoms (DRESS): a national analysis of data from a ten-years post-marketing surveillance. Drug Safety Sept 2015 DOI 10.1007/s40264-015-0343-3 Projects Memberships Member of the Project Team 2 PSUR from 2011 - 2012 Member of the National Group of Experts on Growth Hormone from 2007 Many publications (20) on diabetes therapy and submitted at national conferences Presentations in the national conference on diabetes and growth hormone Predisposition of HTA report Other Relevant Information 10/12/15 © European Union, 2002-2015 | http://europass.cedefop.europa.eu Page 2 / 2